
Sign up to save your podcasts
Or
Erin McCreary (@erinmccreary) and Ryan Shields (@ryankshields) review expanded MERINO trial data including mortality by pathogen MIC, PK-PD principles, BLING III, beta-lactam therapeutic drug monitoring, linezolid dosing in renal impairment, microbiology issues, and updates from EUCAST.
CORRECTION: Piperacillin-tazobactam was dosed 4.5g IV every 6 hours in the Merino trial.
Learn more about the Society of Infectious Diseases Pharmacists: https://sidp.org/About
4.9
159159 ratings
Erin McCreary (@erinmccreary) and Ryan Shields (@ryankshields) review expanded MERINO trial data including mortality by pathogen MIC, PK-PD principles, BLING III, beta-lactam therapeutic drug monitoring, linezolid dosing in renal impairment, microbiology issues, and updates from EUCAST.
CORRECTION: Piperacillin-tazobactam was dosed 4.5g IV every 6 hours in the Merino trial.
Learn more about the Society of Infectious Diseases Pharmacists: https://sidp.org/About
2,058 Listeners
1,868 Listeners
322 Listeners
129 Listeners
25 Listeners
3,334 Listeners
1,138 Listeners
249 Listeners
373 Listeners
183 Listeners
30 Listeners
85 Listeners
233 Listeners
10 Listeners
3 Listeners